Experimental and theoretical investigation of the apomorphine Raman spectrum

Journal of Raman Spectroscopy

Volumn 40, Issue 12, 2009, Pages 2074-2079

  Lucotti, A ^a   Casella, M ^b,c   Tommasini, M ^a   Gramatica, F ^b   Di Fabrizio, E ^c,d   Zerbi, G ^a  

^a POLITECNICO DI MILANO   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Apomorphine; Density functional theory calculations; Drug molecular characterization; Parkinson's disease; Raman spectroscopy

Indexed keywords

AMINES; NEURODEGENERATIVE DISEASES; NEUROPHYSIOLOGY; PATIENT TREATMENT; RAMAN SCATTERING;

APOMORPHINE; DENSITY-FUNCTIONAL THEORY CALCULATIONS; DOPAMINE; DRUG FORMULATIONS; DRUG MOLECULAR CHARACTERIZATION; EXPERIMENTAL INVESTIGATIONS; IN-PLANE BENDING; MOLECULAR CHARACTERIZATION; PARKINSON'S DISEASE; THEORETICAL INVESTIGATIONS;

RAMAN SPECTROSCOPY;

EID: 72249120227     PISSN: 03770486     EISSN: 10974555     Source Type: Journal    
DOI: 10.1002/jrs.2374     Document Type: Article

References (10)

1. A. Mattheisen, Proc. R. Soc. London, Ser. B. Biol. Sci. 1869, 17, 455.
2. R. Menon, M. Stacy, Expert Opin. Pharmacother. 2007, 8, 1941.
3. D. Muguet, E. Broussolle, G. Chazot, Biomed. Pharmacother. 1995, 49, 197.
4. J. Giesecke, Acta Crystallogr. 1973, B29, 1785.
5. J. Giesecke, Acta Crystallogr. 1977, B33, 302.
6. S. C. Pinzaru, I. Pavel, N. Leopold, W. Kiefer, J. Raman Spec. 2004, 35, 338.
7. A. P. Scott, L. Radom, J. Phys. Chem. 1996, 100, 16 502.
8. http://www.nongnu.org/xmakemol
9. http://www.cmbi.ru.nl/molden/molden.html
10. H. Sato, H. Chiba, H. Tashiro, Y. Ozaki, J. Biomed. Opt. 2001, 6, 366.